ImmunoScience, Inc.
ImmunoScience, Inc. is a privately held, small (11-50 employees) San Francisco-based company founded in 1994 with a self-described biochemistry orientation; the source data provides no product, customer, revenue, or operational details.
- Company typePrivate
- Founded1994
- HeadquartersSan Francisco, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
What ImmunoScience, Inc. does
ImmunoScience, Inc. is a privately held, for-profit company headquartered in San Francisco, California, United States, founded in 1994. The firm's self-described positioning is captured by the tagline "Better living through biochemsitry" (sic), and its name and wording indicate an orientation toward biochemistry or immunology-related activity, though no specific products, services, research programs, or technical platform details are described in the available source data.
The company is small, listed at 11-50 employees, and has been operating for roughly three decades. Its only identified public-facing asset, the domain immunoscience.com, currently resolves to a bare Apache 2.4.58 (Ubuntu) directory index page with no substantive content, no product listings, no leadership disclosures, and no press or contact information. There are no published funding rounds, revenue figures, customer logos, partnerships, certifications, regulatory actions, management-team records, M&A events, or restructuring notices in the available data.
The business model, go-to-market motion, pricing structure, and customer segments are all unspecified in the source material. Because the only observable digital footprint is an empty server index, the available data does not confirm any active commercial operations, and the analysis cannot characterize current revenue, growth direction, or strategic posture beyond what is stated above.
ImmunoScience, Inc. firmographics
Firmographics- Name
- ImmunoScience, Inc.
- Website
- https://immunoscience.com
- Company type
- Private
- Founded year
- 1994
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- ImmunoScience, Inc. is a privately held, small (11-50 employees) San Francisco-based company founded in 1994 with a self-described biochemistry orientation; the source data provides no product, customer, revenue, or operational details.
- Ownership category
- akta.pro rank
ImmunoScience, Inc. industry classification
Industry- Product category
- Biotechnology Research Services
- NAICS
- Medical and Diagnostic Laboratories (62151), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- Immunoassay Diagnostics (ELISA, chemiluminescence, serology) (HLAAALAB)
- akta.pro secondary industries
- Clinical Chemistry & Immunoassay Systems (HLAHAAAA), Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry) (HLAGAEAB), Protein Interaction & Structural Biology Platforms (cryo-EM, X-ray, NMR, biophysics) (HLAAAIAH)
Keywords
Where ImmunoScience, Inc. is headquartered
LocationHeadquarters
- HQ city
- San Francisco
- HQ country
- United States
- HQ region
- North America
Markets served
ImmunoScience, Inc. business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel
ImmunoScience, Inc. product offering
Product offeringCore offering
ImmunoScience, Inc. is a San Francisco-based private biotechnology company founded in 1994 operating under the tagline "Better living through biochemsitry." The company's specific products and services are not documented in available sources; its website (immunoscience.com) currently displays only an Apache server directory index page with no substantive content, and no detailed product, service, or technology descriptions are available in the source data.
Differentiator
Problem solved
Functional benefit
Products and services
- Unspecified immunology/biotechnology offerings No discrete, named products or services are documented in the available source material.
Companies that use ImmunoScience, Inc.
Customer profileIdeal customer profiles1 record
ImmunoScience, Inc. technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
ImmunoScience, Inc. partnerships and signals
Strategic signalRecent moves1 record
ImmunoScience, Inc. competitors and assessment
Company assessmentEmerging players
- GenScript: Biotech research services and reagent provider with growing immunoassay/antibody offerings and direct-to-research-customer e-commerce. Comparable as a digitally-native reagent specialist with overlapping immunology/biochemistry scope.
Broad incumbents
- Bio-Techne (including R&D Systems): Developer and supplier of high-quality reagents, immunoassays (ELISA kits, Luminex), and proteins for life-science research. Directly comparable in the specialty immunoassay/biochemistry niche where ImmunoScience appears positioned.
- MilliporeSigma (Sigma-Aldrich / Merck KGaA Life Science): Broad-line supplier of biochemicals, reagents, immunoassay kits, and lab consumables. Comparable incumbent across the biochemistry/immunoassay reagent category ImmunoScience targets.
- Bio-Rad Laboratories: Major life-science instrumentation and clinical diagnostics manufacturer with a deep clinical chemistry and immunoassay portfolio. Highly comparable as an incumbent in the same immunoassay/biochemistry category ImmunoScience appears to occupy, though at vastly greater scale.
- Thermo Fisher Scientific: Largest life-sciences tools and diagnostics company, offering immunoassay reagents, antibodies, and clinical chemistry platforms across research and clinical markets. Comparable as the dominant incumbent ImmunoScience would compete against for any research-lab customer.
Direct peers
- Cell Signaling Technology: Specialty antibody and immunoassay producer focused on signaling pathways and immunology-related research reagents. Comparable as a focused reagent company serving research labs with immunology/biochemistry content.
- Santa Cruz Biotechnology: Independent supplier of research antibodies, immunoassays, and biochemical reagents. Comparable as a privately held specialty immunology/biochemistry reagent vendor competing in the same research-customer niche.
- Abcam: Specialist manufacturer and digital distributor of antibodies and immunoassay-related reagents serving research customers worldwide. Closest peer in business model (specialty reagent maker in immunology/biochemistry), though far more digitized and scaled.
Market position
Strengths3 records
Weaknesses4 records
Competitive moat1 record
Key risks5 records
Key highlights3 records
Customer concentration
ImmunoScience, Inc. social profiles
Digital presenceImmunoScience, Inc. financial estimates
Financial estimateRevenue estimate
Valuation estimate
ImmunoScience, Inc. leadership team
Management profileNumber of profiles
ImmunoScience, Inc. funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
ImmunoScience, Inc. M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about ImmunoScience, Inc.
What does ImmunoScience, Inc. do?
ImmunoScience, Inc. is a San Francisco-based private biotechnology company founded in 1994 operating under the tagline "Better living through biochemsitry." The company's specific products and services are not documented in available sources; its website (immunoscience.com) currently displays only an Apache server directory index page with no substantive content, and no detailed product, service, or technology descriptions are available in the source data.
When was ImmunoScience, Inc. founded?
ImmunoScience, Inc. was founded in 1994. It employs 11 to 50 people.
Where is ImmunoScience, Inc. based?
ImmunoScience, Inc. is headquartered in San Francisco, United States, in the North America region.
Who are ImmunoScience, Inc.'s main competitors?
GenScript is listed as an emerging player. Broad incumbents are Bio-Techne (including R&D Systems), MilliporeSigma (Sigma-Aldrich / Merck KGaA Life Science), Bio-Rad Laboratories and Thermo Fisher Scientific. Direct peers are Cell Signaling Technology, Santa Cruz Biotechnology and Abcam.
Does ImmunoScience, Inc. have an API?
No public API is recorded for ImmunoScience, Inc..
What industry is ImmunoScience, Inc. in?
ImmunoScience, Inc.'s product category is Biotechnology Research Services. Its primary akta.pro industry code is HLAAALAB, Immunoassay Diagnostics (ELISA, chemiluminescence, serology), with a secondary code of HLAHAAAA, Clinical Chemistry & Immunoassay Systems. Its NAICS code is 62151 and its SIC code is 2835.